Related Experiment Video
Updated: Jun 15, 2026
12:19
An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke
Published on: March 11, 2018
Subtle BBB alterations in brain edema associated with acute liver failure.
Neurochemistry International
|March 5, 2010
Summary
Matrix metalloproteinase-9 (MMP-9) contributes to brain edema in acute liver failure (ALF). Blocking MMP-9 reduces edema, suggesting subtle blood-brain barrier alterations are involved.
Area of Science:
- Neuroscience
- Hepatology
- Biochemistry
Background:
- The vasogenic mechanism of brain edema in acute liver failure (ALF) is not fully understood.
- Matrix metalloproteinase-9 (MMP-9) has been implicated in experimental ALF-induced brain edema.
Discussion:
- MMP-9 inhibition, using monoclonal antibodies or synthetic inhibitors, effectively attenuates brain edema in experimental ALF.
- Ultrastructural analysis reveals intact blood-brain barrier (BBB) and its tight junctions, despite edema formation.
Key Insights:
- MMP-9 plays a significant role in the pathogenesis of brain edema during ALF.
- The blood-brain barrier (BBB) integrity may be subtly altered, rather than overtly disrupted, in ALF-associated brain edema.
Outlook:
- Further research into the precise mechanisms of BBB alterations in ALF is warranted.
- Targeting MMP-9 presents a potential therapeutic strategy for managing brain edema in ALF.
More Related Videos
09:35A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
09:04In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
Published on: June 8, 2017
Related Concept Videos
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:19Cerebral Edema l: Introduction
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
00:49The Blood-brain Barrier
Overview
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...